Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorM.D. Anderson Cancer Center

About this trial

To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

stakeholder advisory board members;

patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial;

patients and community members participating in formative research activities;

providers, clinic staff, and other health system stakeholders from partnering health systems;

Disqualifiers

Report being currently pregnant

History of total hysterectomy

History of cervical cancer

Trial design

Design model

Single group

Treatments tested in this trial

  • HR-HPV Testing

    Behavioral

    Given by Interview and focus groups

Treatment groups

7,100 Participants
are divided into 1 treatment group
Group A: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Safety and Adverse Events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 4.03

Time frame
Through study completion; an average of 1 year.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.